[HTML][HTML] Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut
MA Berryman, J Ilonen, EW Triplett… - Frontiers in …, 2023 - frontiersin.org
Human leukocyte antigen (HLA) genes are associated with more diseases than any other
region of the genome. Highly polymorphic HLA genes produce variable haplotypes that are …
region of the genome. Highly polymorphic HLA genes produce variable haplotypes that are …
Prevalence of type 1 and type 2 diabetes in children and adolescents in Germany from 2002 to 2020: A study based on electronic health record data from the DPV …
A Stahl‐Pehe, C Kamrath, N Prinz… - Journal of …, 2022 - Wiley Online Library
Background To provide estimates of the nationwide prevalence of type 1 diabetes (T1D) and
type 2 diabetes (T2D) in individuals younger than 20 years of age in Germany from 2002 to …
type 2 diabetes (T2D) in individuals younger than 20 years of age in Germany from 2002 to …
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study
K Yang, X Yang, C Jin, S Ding, T Liu, B Ma, H Sun… - bmj, 2024 - bmj.com
Objectives To estimate the burden, trends, and inequalities of type 1 diabetes mellitus
(T1DM) among older adults at global, regional, and national level from 1990 to 2019. Design …
(T1DM) among older adults at global, regional, and national level from 1990 to 2019. Design …
Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis
Background Fear of hypoglycaemia (FOH) significantly disrupts the daily management of
type 1 diabetes (T1D) and increases the risk of complications. Recent technological …
type 1 diabetes (T1D) and increases the risk of complications. Recent technological …
[HTML][HTML] Adaptation of an adult web application for type 1 diabetes self-management to youth using the behavior change wheel to tailor the needs of health care …
LF Xie, A Housni, M Nakhla, R Cianci, C Leroux… - JMIR …, 2023 - diabetes.jmir.org
Background: Youth (aged 14-24 years) living with type 1 diabetes (T1D) encounter
increased challenges in their diabetes self-management (DSM), especially during the …
increased challenges in their diabetes self-management (DSM), especially during the …
Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes
A Rabinovitch, D Koshelev… - Frontiers in …, 2023 - frontiersin.org
Introduction The purpose of this retrospective clinic chart review study was to determine the
potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a …
potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a …
[HTML][HTML] Can type 1 diabetes be an unexpected complication of obesity?
P Oboza, N Ogarek… - Frontiers in …, 2023 - frontiersin.org
Type 1 diabetes (T1D) is one of the most common chronic autoimmune diseases,
characterized by absolute insulin deficiency caused via inflammatory destruction of the …
characterized by absolute insulin deficiency caused via inflammatory destruction of the …
N-acetyl-L-cysteine alleviates FUNDC1-mediated mitophagy by regulating mitochondrial dynamics in type 1 diabetic nephropathy canine
F Ma, H Li, H Huo, Q Han, J Liao, H Zhang, Y Li, J Pan… - Life Sciences, 2023 - Elsevier
Diabetic nephropathy (DN) is a major complication of type 1 diabetes mellitus, and
hyperglycemia and hypertension are the main risk factors for the development of DN. N …
hyperglycemia and hypertension are the main risk factors for the development of DN. N …
[PDF][PDF] Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study
OBJECTIVE We explored longitudinal changes associated with switching to hybrid closed-
loop (HCL) insulin delivery systems in adults with type 1 diabetes and elevated HbA1c …
loop (HCL) insulin delivery systems in adults with type 1 diabetes and elevated HbA1c …